论文部分内容阅读
目的:观察厄贝沙坦治疗高血压合并高尿酸血症的疗效。方法:高血压合并高尿酸血症患者90例随机分为治疗组和对照组各45例,治疗组给予厄贝沙坦,对照组给予钙离子拮抗剂或β受体阻滞剂等,疗程均为12周。比较2组治疗前、后血压、血尿酸水平。结果:2组治疗后收缩压、舒张压均较治疗前下降(P<0.05),2组间比较差异无统计学意义(P>0.05);治疗组治疗后血尿酸水平较治疗前下降,对照组治疗前、后比较差异无统计学意义(P>0.05),2组比较差异有统计学意义(P<0.05)。结论:厄贝沙坦降压同时能有效降低血尿酸。
Objective: To observe the curative effect of irbesartan on hypertension and hyperuricemia. Methods: 90 hypertensive patients with hyperuricemia were randomly divided into treatment group and control group, 45 cases in each group, irbesartan in treatment group and calcium antagonist or β-blocker in control group For 12 weeks. Compare the two groups before and after treatment, blood pressure, serum uric acid levels. Results: The systolic blood pressure and diastolic blood pressure in the two groups were significantly lower than those before treatment (P <0.05), but there was no significant difference between the two groups (P> 0.05). The serum uric acid level of the treatment group decreased after treatment, There was no significant difference between the two groups before and after treatment (P> 0.05). The difference between the two groups was statistically significant (P <0.05). Conclusion: Irbesartan can reduce blood pressure and blood uric acid at the same time.